Undiagnosed airflow limitation in patients at cardiovascular risk

Archives of Cardiovascular Diseases

Volumn 104, Issue 12, 2011, Pages 619-626

  Bérard, Emilie ^a   Bongard, Vanina ^a   Roche, Nicolas ^b   Perez, Thierry ^c   Brouquires, Dany ^d   Taraszkiewicz, Dorota ^d   Fievez, Stéphane ^e   Denis, Franois ^f   Escamilla, Roger ^d   Ferrires, Jean ^a,d  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b HÔTEL DIEU   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e PFIZER INC   (United States)

^f BOEHRINGER INGELHEIM   (France)

Author keywords

Airflow limitation; Cardiovascular risk; COPD; Prevalence; Spirometry

Indexed keywords

ADULT; AIRFLOW; AIRFLOW LIMITATION; ARTICLE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PATIENT REFERRAL; PHYSICAL EXAMINATION; QUESTIONNAIRE; SMOKING; SOCIOECONOMICS; SPIROMETRY; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SPIROMETRY; VITAL CAPACITY;

EID: 82955233886     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2011.10.002     Document Type: Article

References (41)

1. A.D. Lopez, K. Shibuya, and C. Rao Chronic obstructive pulmonary disease: current burden and future projections Eur Respir J 27 2006 397 412 (Pubitemid 43180921)
2. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1498 1504 (Pubitemid 27216360)
3. G.J. Huchon, A. Vergnengre, and F. Neukirch Chronic bronchitis among French adults: high prevalence and underdiagnosis Eur Respir J 20 2002 806 812 (Pubitemid 35175113)
4. B.R. Celli, W. MacNee ATS/ERS Task Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946 (Pubitemid 38807371)
5. J. Finkelstein, E. Cha, and S.M. Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int J Chron Obstruct Pulmon Dis 4 2009 337 349
6. S.M. Curkendall, C. DeLuise, and J.K. Jones Cardiovascular disease in patients with chronic obstructive pulmonary disease. Saskatchewan Canada cardiovascular disease in COPD patients Ann Epidemiol 16 2006 63 70 (Pubitemid 41783891)
7. D.D. Sin, and S.F.P. Man Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease Can J Physiol Pharmacol 83 2005 8 13 (Pubitemid 40754770)
8. S. Sidney, M. Sorel, and C.P. Quesenberry COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanent care program Chest 128 2005 2068 2075 (Pubitemid 41507542)
9. D.M. Mannino, D. Thorn, and A. Swensen Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPD Eur Respir J 32 2008 962 969
10. H.A. Hadi, M. Zubaid, and W. Al Mahmeed Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome Clin Cardiol 33 2010 228 235
11. N.M. Hawkins, Z. Huang, and K.S. Pieper Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Eur J Heart Fail 11 2009 292 298
12. F. Bursi, R. Vassallo, and S.A. Weston Chronic obstructive pulmonary disease after myocardial infarction in the community Am Heart J 160 2010 95 101
13. J.B. Soriano, F. Rigo, and D. Guerrero High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease Chest 137 2010 333 340
14. A.C. Salisbury, K.J. Reid, and J.A. Spertus Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes Am J Cardiol 99 2007 636 641
15. S.C. Gan, S.K. Beaver, and P.M. Houck Treatment of acute myocardial infarction and 30-day mortality among women and men N Engl J Med 343 2000 8 15 (Pubitemid 30447986)
16. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. Available from: http://www.goldcopd.org/.
17. N.S. Godtfredsen, T.H. Lam, and T.T. Hansel COPD-related morbidity and mortality after smoking cessation: status of the evidence Eur Respir J 32 2008 844 853
18. D. Halpin Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena COPD 5 2008 187 200 (Pubitemid 351892734)
19. J. Ferrires, J.P. Cambou, and J.B. Ruidavets Trends in acute myocardial infarction prognosis and treatment in southwestern France between 1985 and 1990 (the MONICA Project-Toulouse) Am J Cardiol 75 1995 1202 1205
20. M. Cournot, D. Taraszkiewicz, and J.P. Cambou Additional prognostic value of physical examination, exercise testing, and arterial ultrasonography for coronary risk assessment in primary prevention Am Heart J 158 2009 845 851
21. J.C. Bestall, E.A. Paul, and R. Garrod Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581 586 (Pubitemid 29296676)
22. R. De Marco, S. Accordini, and I. Cerveri An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages Thorax 59 2004 120 125 (Pubitemid 38223482)
23. R. Rabin, and F. de Charro EQ-5D: a measure of health status from the EuroQol Group Ann Med 33 2001 337 343 (Pubitemid 32675374)
24. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 1978 499 502
25. P.W. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
26. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338 (Pubitemid 41079078)
27. R. Pellegrino, G. Viegi, and V. Brusasco Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968 (Pubitemid 41632054)
28. N. Roche, F. Dalmay, and T. Perez Impact of chronic airflow obstruction in a working population Eur Respir J 31 2008 1227 1233
29. J.C. Guerin, J.P. Baud, and J.C. Besson Étude observationnelle DEPISTRA : dépistage de la BPCO en médecine du travail en Rhône-Alpes Rev Mal Respir 26 2009 48 49
30. A.S. Buist, M.A. McBurnie, and W.M. Vollmer International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 2007 741 750 (Pubitemid 47321907)
31. S.M. Curkendall, S. Lanes, and C. de Luise Chronic obstructive pulmonary disease severity and cardiovascular outcomes Eur J Epidemiol 21 2006 803 813 (Pubitemid 44885203)
32. G.C. Donaldson, J.R. Hurst, and C.J. Smith Increased risk of myocardial infarction and stroke following exacerbation of COPD Chest 137 2010 1091 1097
33. J.L. Izquierdo, A. Martínez, and E. Guzmán Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors Int J Chron Obstruct Pulmon Dis 5 2010 387 394
34. V.E. Friedewald, P. Ganz, and J.M. Kremer AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease Am J Cardiol 106 2010 442 447
35. L. Fabbri, and K. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799 (Pubitemid 47320803)
36. F. Pitta, T. Troosters, and M.A. Spruit Characteristics of physical activities in daily life in chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 972 977 (Pubitemid 40616945)
37. J. Garcia-Aymerich, P. Lange, and M. Benet Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study Thorax 61 2006 772 778 (Pubitemid 44369401)
38. J. Garcia-Aymerich, P. Lange, and M. Benet Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study Am J Respir Crit Care Med 175 2007 458 463 (Pubitemid 46354249)
39. J. Garcia-Aymerich, I. Serra, and F. Gomez Physical activity and clinical and functional status in COPD Chest 136 2009 62 70
40. R. de Marco, S. Accordini, and I. Cerveri Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm Am J Respir Crit Care Med 175 2007 32 39 (Pubitemid 46105306)
41. E.M. Kallergis, E.G. Manios, and E.M. Kanoupakis Acute electrophysiologic effects of inhaled salbutamol in humans Chest 127 2005 2057 2063